This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1991:93:215-7.

doi: 10.1159/000420222.

Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration

Y Ohtake¹, H Hirasawa, T Sugai, S Oda, H Shiga, K Matsuda, N Kitamura

Affiliations

PMID: 1666354
DOI: 10.1159/000420222

Comparative Study

Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration

Y Ohtake et al. Contrib Nephrol. 1991.

. 1991:93:215-7.

doi: 10.1159/000420222.

Authors

Y Ohtake¹, H Hirasawa, T Sugai, S Oda, H Shiga, K Matsuda, N Kitamura

Affiliation

¹ Department of Emergency and Critical Care Medicine, Chiba University School of Medicine, Japan.

PMID: 1666354
DOI: 10.1159/000420222

No abstract available

PubMed Disclaimer

Similar articles

[Use of anticoagulant in continuous hemodiafiltration therapy].
Odaka M. Odaka M. Nihon Rinsho. 1991 Dec;49 Suppl:468-71. Nihon Rinsho. 1991. PMID: 1808302 Japanese. No abstract available.
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE. Hirsh J, et al. Chest. 1998 Nov;114(5 Suppl):489S-510S. doi: 10.1378/chest.114.5_supplement.489s. Chest. 1998. PMID: 9822059 Review. No abstract available.
[Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
Ryckelynck JP, Chouraqui D, Lobbedez T. Ryckelynck JP, et al. Nephrologie. 1998;19(4):223-5. Nephrologie. 1998. PMID: 9675763 Review. French.
Comparison of nafamostat mesilate and unfractionated heparin as anticoagulants during continuous renal replacement therapy.
Makino S, Egi M, Kita H, Miyatake Y, Kubota K, Mizobuchi S. Makino S, et al. Int J Artif Organs. 2016 Jan;39(1):16-21. doi: 10.5301/ijao.5000465. Epub 2016 Feb 9. Int J Artif Organs. 2016. PMID: 26868216
Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)?
Matsuo T, Matsuo M, Ouga-Maruyama S. Matsuo T, et al. Thromb Haemost. 2001 Oct;86(4):1115-6. Thromb Haemost. 2001. PMID: 11686333 No abstract available.

See all similar articles

Cited by

The role of nafamostat mesylate anticoagulation in continuous kidney replacement therapy for critically ill patients with bleeding tendencies: a retrospective study on patient outcomes and safety.
Kim T, Kim DE, Jo EM, Lee Y, Kim DW, Kim HJ, Seong EY, Song SH, Rhee H. Kim T, et al. Kidney Res Clin Pract. 2024 Jul;43(4):469-479. doi: 10.23876/j.krcp.23.310. Epub 2024 Jun 13. Kidney Res Clin Pract. 2024. PMID: 38934038 Free PMC article.
The Molecular Aspect of Antitumor Effects of Protease Inhibitor Nafamostat Mesylate and Its Role in Potential Clinical Applications.
Chen X, Xu Z, Zeng S, Wang X, Liu W, Qian L, Wei J, Yang X, Shen Q, Gong Z, Yan Y. Chen X, et al. Front Oncol. 2019 Sep 3;9:852. doi: 10.3389/fonc.2019.00852. eCollection 2019. Front Oncol. 2019. PMID: 31552177 Free PMC article. Review.
Identification of impurities in nafamostat mesylate using HPLC-IT-TOF/MS: A series of double-charged ions.
Zhang Y, An L, Zhang L, Wang R, Tian Y, Zhang Z. Zhang Y, et al. J Pharm Anal. 2020 Aug;10(4):346-350. doi: 10.1016/j.jpha.2020.03.002. Epub 2020 Mar 3. J Pharm Anal. 2020. PMID: 32923008 Free PMC article.
Integration of transcriptomics and metabolomics reveals the molecular mechanisms underlying the effect of nafamostat mesylate on rhabdomyolysis-induced acute kidney injury.
Guo W, Wang Y, Wu Y, Liu J, Li Y, Wang J, Ou S, Wu W. Guo W, et al. Front Pharmacol. 2022 Nov 29;13:931670. doi: 10.3389/fphar.2022.931670. eCollection 2022. Front Pharmacol. 2022. PMID: 36532745 Free PMC article.
Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study.
Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Monchi M, et al. Intensive Care Med. 2004 Feb;30(2):260-265. doi: 10.1007/s00134-003-2047-x. Epub 2003 Nov 5. Intensive Care Med. 2004. PMID: 14600809 Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information